Last update 08 May 2025

ZVS-203e

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
RHO gene therapy (Beijing Chinagene Technology)
Target
RP4
Action-
Mechanism
RHO gene transference
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication
Retinitis Pigmentosa
Inactive Indication-
Originator Organization
Beijing Chigenovo Co., Ltd.Beijing Chigenovo Co., Ltd.
Active Organization
Beijing Chigenovo Co., Ltd.Beijing Chigenovo Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

2
Clinical Trials associated with ZVS-203e
NCT06952842
/ Not yet recruitingPhase 1/2
A Single-Arm, Open-Label, Phase 1/2 Clinical Trial of ZVS203e in Subjects With Retinitis Pigmentosa Associated With RHO Mutation
NCT05805007
/ RecruitingEarly Phase 1IIT
A Single-arm, Open-label Exploratory Clinical Study to Assess the Preliminary Safety of the Gene Editing Drug ZVS203e for the Management of Retinitis Pigmentosa Caused by Mutations in the RHO Gene
100 Clinical Results associated with ZVS-203e
Login to view more data
100 Translational Medicine associated with ZVS-203e
Login to view more data
100 Patents (Medical) associated with ZVS-203e
Login to view more data
100 Deals associated with ZVS-203e
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinitis PigmentosaPhase 2
China
Beijing Chigenovo Co., Ltd.Beijing Chigenovo Co., Ltd.
18 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free